An Integrated Early Phase Ecosystem
hVIVO is a science led early phase drug development company operating an integrated ecosystem built to meet the growing complexity of modern clinical research. The Company combines specialist clinical sites, advanced virology and immunology laboratories, human challenge expertise, and early drug development consulting to generate rigorous, decision ready human data earlier in development. This unified model reduces uncertainty, accelerates progression, and provides sponsors with a clearer understanding of mechanism, dose, and early efficacy.
With world leading capabilities in respiratory and infectious disease and expanding expertise in cardiometabolic and other high growth therapeutic areas, hVIVO supports a global client base that includes seven of the world’s ten largest biopharmaceutical companies. Its purpose built quarantine facilities in London are the largest human challenge units in the world, complemented by additional early phase capacity in Germany and continuous volunteer recruitment through FluCamp. By integrating scientific insight with operational control, hVIVO delivers the clarity, speed, and reliability required to advance new medicines with confidence.
Our Services
Clinical
hVIVO supports the full journey from preclinical to Phase III, transforming early Phase I data into clear direction for your product’s next steps. We enable fast success — or fast, informed failure — so you can make smarter decisions sooner.
Our integrated expertise includes:
-
Rapid delivery of safety data & insights through FiH/SAD/MAD/DDI studies in our clinical pharmacology unit combined with our biometry consultancy
-
Accelerate the PoC & efficacy data for your vaccine or anti-viral leveraging our globally recognised Human Challenge Trials using our world-class quarantine facility
-
Expert-led design, rapid recruitment and advanced diagnostic capabilities delivered through our sites in UK and Germany to advance your Phase II/III studies
Challenge
Building on decades of unrivalled experience, hVIVO is a leading CRO with world-class expertise in delivering human challenge trials, challenge agent manufacture, a unique portfolio of infectious and respiratory disease models, and specialist drug development and clinical consultancy services.
Labs
hVIVO has a highly specialised infectious disease and immunology laboratory offering a suite of services to support pre-clinical and drug and vaccine discovery & development.
hVIVO have extended their storage offering to the biotech and pharmaceutical industries with locations in London and Cambridge, offering a dedicated GxP storage facility for biological and clinical materials in secure temperature-controlled conditions.
Consulting
hVIVO's integrated drug development consultancy supports life science innovators from early planning through clinical execution. With more than 25-years of experience, our team delivers a uniquely combined offering across CMC, non-clinical, clinical pharmacology, regulatory, data management and (translational) laboratory services, across the drug development and market authorisation spectrum.
